Advertisement

Double Immunohistochemistry and Digital Image Analysis

  • Pablo Moreno-RuizEmail author
  • Lina Wik Leiss
  • Artur Mezheyeuski
  • Monika Ehnman
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1913)

Abstract

Immunohistochemistry (IHC) is a commonly used technique for protein detection in tissue sections. The method requires high-affinity antibodies that are specific for the target proteins of interest. More advanced IHC techniques have been developed to meet the need for simultaneous detection of more than one target protein in the same tissue section. This chapter provides general guidelines for double IHC staining of formalin-fixed, paraffin-embedded tissue sections. Chromogenic substrates are chosen based on their excellent contrast and compatibility with the subsequent digital image analysis.

Key words

FFPE Double immunohistochemistry Antibody Chromogenic substrate Digital image analysis 

Notes

Acknowledgments

This work was supported by the Svenska Institutet to AM, the Swedish Childhood Cancer Fund (Barncancerfonden) and the Tornspiran Foundation (Stiftelsen Tornspiran) to ME, and the Knut and Alice Wallenberg Foundation to PM.

References

  1. 1.
    Perez EA, Cortés J, Gonzalez-Angulo AM, Bartlett JMS (2014) HER2 testing: current status and future directions. Cancer Treat Rev 40:276–284.  https://doi.org/10.1016/j.ctrv.2013.09.001CrossRefPubMedGoogle Scholar
  2. 2.
    Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820.  https://doi.org/10.1007/s00401-016-1545-1CrossRefPubMedGoogle Scholar
  3. 3.
    Frödin M, Mezheyeuski A, Corvigno S et al (2016) Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma. Br J Cancer 116(2):195–201.  https://doi.org/10.1038/bjc.2016.407CrossRefGoogle Scholar
  4. 4.
    Mezheyeuski A, Bradic Lindh M, Kyrre Guren T et al (2014) Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer. Oncotarget 7:41948–41958.  https://doi.org/10.18632/oncotarget.9632CrossRefGoogle Scholar
  5. 5.
    Corvigno S, Wisman GBA, Mezheyeuski A et al (2016) Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: inter- and intra-patient heterogeneity and impact on survival. Oncotarget 7:18573–18584.  https://doi.org/10.18632/oncotarget.7613CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Corvigno S, Frödin M, Bea G et al (2017) Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker. J Pathol Clin Res 3:214–224.  https://doi.org/10.1002/cjp2.74CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Leong TY, Leong AS (2007) How does antigen retrieval work? Adv Anat Pathol 14:129–131.  https://doi.org/10.1097/pap.0b013e31803250c7CrossRefPubMedGoogle Scholar
  8. 8.
    Ramos-Vara JA (2017) Principles and methods of immunohistochemistry. Humana Press, New York, NY, pp 115–128Google Scholar
  9. 9.
    Boenisch T (2007) Pretreatment for immunohistochemical staining simplified. Appl Immunohistochem Mol Morphol 15:208–212.  https://doi.org/10.1097/01.pai.0000209862.28205.e6CrossRefPubMedGoogle Scholar
  10. 10.
    Smith A (2014) Finding the best antibody dilution by repeated immunostaining of the same tissue section. Biotech Histochem 89:215–219.  https://doi.org/10.3109/10520295.2013.834074CrossRefPubMedGoogle Scholar
  11. 11.
    Nguyen D, Nguyen D (2013) Quantifying chromogen intensity in immunohistochemistry via reciprocal intensity. Protoc Exch.  https://doi.org/10.1038/protex.2013.097

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Pablo Moreno-Ruiz
    • 1
    Email author
  • Lina Wik Leiss
    • 1
    • 2
  • Artur Mezheyeuski
    • 3
  • Monika Ehnman
    • 1
  1. 1.Department of Oncology-PathologyKarolinska InstitutetStockholmSweden
  2. 2.Neuro ClinicHaukeland University HospitalBergenNorway
  3. 3.Department of Immunology, Genetics and PathologyUppsala UniversityUppsalaSweden

Personalised recommendations